Open access
Aug 2026
Integrated Bioinformatic and Experimental Analysis Reveals the Molecular Mechanisms Underlying KDM1B/LSD2 Inhibition as a Therapeutic Strategy in Human Lung Adenocarcinoma.
Findings highlight KDM1B as a valuable therapeutic target in lung adenocarcinoma and emphasize its key role in lung cancer development.
K. Muthiah, S. Natarajan, U. Dhawan et al.
· Journal of Cellular Biochemi... · 0 citations